Capstone Investment Advisors, LLC Legend Biotech Corp Transaction History

Capstone Investment Advisors, LLC

  • $38.9 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$43.55 - $59.88 $46,946 - $64,550
-1,078 Reduced 16.64%
5,399 $263,000
Q2 2024

Aug 14, 2024
BUY
$39.5 - $57.22 $255,841 - $370,613
6,477 New
6,477 $286,000
Q4 2023

Feb 12, 2024
SELL
$57.25 - $69.74 $152,456 - $185,717
-2,663 Reduced 36.67%
4,599 $276,000
Q3 2023

Nov 13, 2023
BUY
$63.16 - $76.5 $458,667 - $555,543
7,262 New
7,262 $487,000

Others Institutions Holding LEGN

# of Institutions
232
Shares Held
84M
Call Options Held
260K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.08B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email